{"parse":{"title":"Monitoring in clinical trials","pageid":2221252,"revid":823519423,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-move\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/52/Merge-arrows.svg/50px-Merge-arrows.svg.png\" width=\"50\" height=\"20\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/52/Merge-arrows.svg/75px-Merge-arrows.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/52/Merge-arrows.svg/100px-Merge-arrows.svg.png 2x\" data-file-width=\"50\" data-file-height=\"20\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">It has been suggested that this article be <a href=\"/wiki/Wikipedia:Merging\" title=\"Wikipedia:Merging\">merged</a> with <i><a href=\"/wiki/Safety_monitoring\" title=\"Safety monitoring\">Safety monitoring</a></i>. (<a href=\"/wiki/Talk:Monitoring_in_clinical_trials\" title=\"Talk:Monitoring in clinical trials\">Discuss</a>)<small><i> Proposed since November 2017.</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Unreferenced\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>does not <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">cite</a> any <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">sources</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href=\"/wiki/Wikipedia:Verifiability#Burden_of_evidence\" title=\"Wikipedia:Verifiability\">removed</a>.</span>  <small><i>(June 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b>Clinical monitoring</b> is the oversight and administrative efforts that monitor a participant's health and efficacy of the treatment during a <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a>. Both independent and government-run grant-funding agencies, such as the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health (NIH)</a><sup id=\"cite_ref-:0_1-0\" class=\"reference\"><a href=\"#cite_note-:0-1\">&#91;1&#93;</a></sup> and the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization (WHO)</a><sup id=\"cite_ref-:1_2-0\" class=\"reference\"><a href=\"#cite_note-:1-2\">&#91;2&#93;</a></sup>, require data and safety monitoring protocols for Phase I and II clinical trials conforming to their standards<sup id=\"cite_ref-:2_3-0\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Aspects_of_monitoring\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Aspects of monitoring</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Functions_of_the_clinical_monitor\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Functions of the clinical monitor</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Complexity_of_monitoring\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Complexity of monitoring</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Aspects_of_monitoring\">Aspects of monitoring</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=1\" title=\"Edit section: Aspects of monitoring\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>According to the <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">U.S. Food and Drug Administration</a>'s Center of Drug Evaluation and Research, the top five deficiency categories for site inspections caught by clinical monitors as reported in the 2001 Report to the Nation<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> are:\n</p>\n<ul><li>Failure to follow investigation protocol (the procedures and treatment subjects must undergo, as well as the schedule of assessments)</li>\n<li>Failure to keep adequate and accurate records</li>\n<li>Problems with the <a href=\"/wiki/Informed_consent\" title=\"Informed consent\">informed consent</a> form</li>\n<li>Failure to report adverse events</li>\n<li>Failure to account for the disposition of study drugs</li></ul>\n<p>Therefore, the primary goal of clinical trial monitoring is to observe each trial site to ensure that the standardized operation procedures for the trial are being followed, reporting and managing any deviations from the investigation plan as they occur. Monitoring plans in the United States typically also require a clear protocol for reporting <a href=\"/wiki/Adverse_event\" title=\"Adverse event\">adverse/undesirable effects</a> caused by the treatment to the <a href=\"/wiki/Institutional_review_board\" title=\"Institutional review board\">institutional review board (IRB)</a>, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">US Food &amp; Drug Administration (FDA)</a>, and the institution funding the research.<sup id=\"cite_ref-:2_3-1\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-:3_5-0\" class=\"reference\"><a href=\"#cite_note-:3-5\">&#91;5&#93;</a></sup> The FDA itself maintains an <a href=\"/wiki/Adverse_Event_Reporting_System\" title=\"Adverse Event Reporting System\">Adverse Event Reporting System</a> for such occurrences in clinical trials it oversees in the United States.\n</p>\n<h2><span class=\"mw-headline\" id=\"Functions_of_the_clinical_monitor\">Functions of the clinical monitor</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=2\" title=\"Edit section: Functions of the clinical monitor\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Clinical monitors execute the monitoring plan laid out by the sponsors and investigators of a clinical trial. Monitors may be referred to by many different titles, such as: <a href=\"/wiki/Clinical_Research_Associate\" class=\"mw-redirect\" title=\"Clinical Research Associate\">Clinical Research Associate</a>, \"on-site\" monitor, Clinical Research Monitor, Study Site Monitor and Quality Specialist. The number of clinical monitors depends on the scale and scope of the trial.\n</p><p>Almost all field monitoring requires regular visits to the site by the clinical research associate throughout the period of the study<sup id=\"cite_ref-:0_1-1\" class=\"reference\"><a href=\"#cite_note-:0-1\">&#91;1&#93;</a></sup>. On occasion, an extremely simple, low-risk study might be monitored almost exclusively by telephone except for the startup and closeout visits. Since the concept of \"low risk\" is subjective, this definition should be established in internal policies and procedures.\n</p>\n<h2><span class=\"mw-headline\" id=\"Complexity_of_monitoring\">Complexity of monitoring</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=3\" title=\"Edit section: Complexity of monitoring\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The level of scrutiny of monitoring varies across studies based on risks and nature of the trial. \n</p><p>Considerations that affect the design of monitoring plans usually include<sup id=\"cite_ref-:3_5-1\" class=\"reference\"><a href=\"#cite_note-:3-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-:2_3-2\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup>:\n</p>\n<ul><li>Complexity of the protocol (including toxicity, presence of special populations inside sample groups, amount of interaction needed, length of treatment, etc.)</li>\n<li>Risk of the treatment</li>\n<li>Disease being evaluated</li>\n<li>Number of study subjects enrolled at the site</li>\n<li>Number of treatment sites (such as number of clinics with access to and assigning the treatment)</li>\n<li>Site performance</li>\n<li>Sponsor monitoring standard operating protocols</li></ul>\n<p>Several of these factors depend on the <a href=\"/wiki/Phases_of_clinical_research\" title=\"Phases of clinical research\">phase</a> of the clinical trial--for example, in some early Phase I studies of drugs whose effects on different individuals are unknown, the monitor may be required to be present during all or part of a subject's treatment, while Phase II investigations usually involve multiple investigation sites<sup id=\"cite_ref-:1_2-1\" class=\"reference\"><a href=\"#cite_note-:1-2\">&#91;2&#93;</a></sup>.\n</p><p>The overall monitoring plan should remain fairly consistent, but the strategy for individual sites may change considerably during the course of the study depending on study conditions and site performance.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trials</a></li>\n<li><a href=\"/wiki/Data_monitoring_committee\" title=\"Data monitoring committee\">Data monitoring committee</a></li>\n<li><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a></li>\n<li><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a></li>\n<li><a href=\"/wiki/Safety_monitoring\" title=\"Safety monitoring\">Safety monitoring</a></li>\n<li><a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">U.S. Food and Drug Administration</a> (FDA)</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-:0-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nimh.nih.gov/funding/clinical-research/data-and-safety-monitoring-plan-writing-guidance.shtml\">\"NIMH&#160;\u00bb Data and Safety Monitoring Plan Writing Guidance\"</a>. <i>www.nimh.nih.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-11-29</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.nimh.nih.gov&amp;rft.atitle=NIMH+%C2%BB+Data+and+Safety+Monitoring+Plan+Writing+Guidance&amp;rft_id=https%3A%2F%2Fwww.nimh.nih.gov%2Ffunding%2Fclinical-research%2Fdata-and-safety-monitoring-plan-writing-guidance.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMonitoring+in+clinical+trials\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/medicinedocs/documents/s14084e/s14084e.pdf\">\"Handbook for Good Clinical Research Practice (GCP)\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>World Health Organization</i>. 2005.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=Handbook+for+Good+Clinical+Research+Practice+%28GCP%29&amp;rft.date=2005&amp;rft_id=http%3A%2F%2Fapps.who.int%2Fmedicinedocs%2Fdocuments%2Fs14084e%2Fs14084e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMonitoring+in+clinical+trials\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:2_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-038.html\">\"NIH Guide:  FURTHER GUIDANCE ON A DATA AND SAFETY MONITORING FOR PHASE I AND PHASE II TRIALS\"</a>. <i>grants.nih.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-11-30</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=grants.nih.gov&amp;rft.atitle=NIH+Guide%3A++FURTHER+GUIDANCE+ON+A+DATA+AND+SAFETY+MONITORING+FOR+PHASE+I+AND+PHASE+II+TRIALS&amp;rft_id=https%3A%2F%2Fgrants.nih.gov%2Fgrants%2Fguide%2Fnotice-files%2FNOT-OD-00-038.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMonitoring+in+clinical+trials\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://aspe.hhs.gov/report/performance-improvement-2003/center-drug-evaluation-and-research\">\"Center for Drug Evaluation and Research\"</a>. <i>ASPE</i>. 2015-11-23<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-11-30</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ASPE&amp;rft.atitle=Center+for+Drug+Evaluation+and+Research&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Faspe.hhs.gov%2Freport%2Fperformance-improvement-2003%2Fcenter-drug-evaluation-and-research&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMonitoring+in+clinical+trials\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/downloads/Drugs/Guidances/UCM269919.pdf\">\"Guidance for Industry: Oversight of Clinical Investigations\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>US Food and Drug Administration</i>. August 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=US+Food+and+Drug+Administration&amp;rft.atitle=Guidance+for+Industry%3A+Oversight+of+Clinical+Investigations&amp;rft.date=2013-08&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2FGuidances%2FUCM269919.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMonitoring+in+clinical+trials\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Monitoring_in_clinical_trials&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090207171103/http://nursing.msu.edu/cracrc.aspx\">Michigan State University CRA Monitor Training Online</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org/\">ICH Website: Guidelines for Clinical Trial Monitoring</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/\">FDA Website</a></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Research_participant_rights\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Research_participant_rights\" title=\"Template:Research participant rights\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Research_participant_rights\" title=\"Template talk:Research participant rights\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Research_participant_rights&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Research_participant_rights\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Research_participant\" title=\"Research participant\">Research participant</a> rights</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Rights</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Beneficence_(ethics)\" title=\"Beneficence (ethics)\">Beneficence</a></li>\n<li><a href=\"/wiki/Justice_(ethics)\" title=\"Justice (ethics)\">Justice</a></li>\n<li><a href=\"/wiki/Respect_for_persons\" title=\"Respect for persons\">Respect for persons</a></li>\n<li><a href=\"/wiki/Privacy_for_research_participants\" title=\"Privacy for research participants\">Privacy for research participants</a></li>\n<li><a href=\"/wiki/Right_to_withdraw\" title=\"Right to withdraw\">Right to withdraw</a></li>\n<li><a href=\"/wiki/Return_of_results\" title=\"Return of results\">Return of results</a></li>\n<li><a href=\"/wiki/Informed_consent\" title=\"Informed consent\">Informed consent</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Human_subject_research\" title=\"Human subject research\">Human subject research</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Clinical_research\" title=\"Clinical research\">Clinical research</a></li>\n<li><a href=\"/wiki/Biobank\" title=\"Biobank\">Biobank</a></li>\n<li><a href=\"/wiki/Social_research\" title=\"Social research\">Social research</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Ethical systems</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Research_ethics\" class=\"mw-redirect\" title=\"Research ethics\">Research ethics</a></li>\n<li><a href=\"/wiki/Medical_ethics\" title=\"Medical ethics\">Medical ethics</a></li>\n<li><a href=\"/wiki/Bioethics\" title=\"Bioethics\">Bioethics</a></li>\n<li><a href=\"/wiki/Clinical_research_ethics\" title=\"Clinical research ethics\">Clinical research ethics</a></li>\n<li><a href=\"/wiki/Biobank_ethics\" title=\"Biobank ethics\">Biobank ethics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Guidelines_for_human_subject_research\" title=\"Guidelines for human subject research\">Guidelines for human subject research</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/List_of_medical_ethics_cases\" title=\"List of medical ethics cases\">List of medical ethics cases</a></li>\n<li><a href=\"/wiki/Nuremberg_Code\" title=\"Nuremberg Code\">Nuremberg Code</a></li>\n<li><a href=\"/wiki/Declaration_of_Helsinki\" title=\"Declaration of Helsinki\">Declaration of Helsinki</a></li>\n<li><a href=\"/wiki/Belmont_Report\" title=\"Belmont Report\">Belmont Report</a></li>\n<li><a href=\"/wiki/Common_Rule\" title=\"Common Rule\">Common Rule</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a class=\"mw-selflink selflink\">Monitoring in clinical trials</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ethics_committee\" title=\"Ethics committee\">Ethics committee</a></li>\n<li><a href=\"/wiki/Institutional_review_board\" title=\"Institutional review board\">Institutional review board</a></li>\n<li><a href=\"/wiki/Data_monitoring_committee\" title=\"Data monitoring committee\">Data monitoring committee</a></li>\n<li><a href=\"/wiki/Community_advisory_board\" title=\"Community advisory board\">Community advisory board</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2193\nCached time: 20180913102356\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.132 seconds\nReal time usage: 0.184 seconds\nPreprocessor visited node count: 588/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 24239/2097152 bytes\nTemplate argument size: 331/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 6071/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.056/10.000 seconds\nLua memory usage: 2.74 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  146.253      1 -total\n 43.67%   63.863      1 Template:Reflist\n 31.04%   45.403      1 Template:Merge\n 29.30%   42.851      4 Template:Cite_web\n 12.71%   18.584      1 Template:Mbox\n 12.61%   18.447      1 Template:Unreferenced\n 10.77%   15.753      1 Template:Ambox\n  8.35%   12.209      1 Template:Research_participant_rights\n  7.37%   10.779      1 Template:DMC\n  6.38%    9.328      1 Template:Navbox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:2221252-0!canonical and timestamp 20180913102356 and revision id 823519423\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/Monitorizaci%C3%B3n_en_ensayos_cl%C3%ADnicos","langname":"Spanish","autonym":"espa\u00f1ol","*":"Monitorizaci\u00f3n en ensayos cl\u00ednicos"}],"categories":[{"sortkey":"","hidden":"","*":"Articles_to_be_merged_from_November_2017"},{"sortkey":"","hidden":"","*":"All_articles_to_be_merged"},{"sortkey":"","hidden":"","*":"Articles_lacking_sources_from_June_2014"},{"sortkey":"","hidden":"","*":"All_articles_lacking_sources"},{"sortkey":"","*":"Clinical_research"},{"sortkey":"","*":"Medical_monitoring"},{"sortkey":"","*":"Pharmaceutical_industry"}],"links":[{"ns":14,"exists":"","*":"Category:Articles to be merged from November 2017"},{"ns":14,"exists":"","*":"Category:Articles lacking sources from June 2014"},{"ns":10,"exists":"","*":"Template:Research participant rights"},{"ns":0,"exists":"","*":"Adverse Event Reporting System"},{"ns":0,"exists":"","*":"Adverse event"},{"ns":0,"exists":"","*":"Belmont Report"},{"ns":0,"exists":"","*":"Beneficence (ethics)"},{"ns":0,"exists":"","*":"Biobank"},{"ns":0,"exists":"","*":"Biobank ethics"},{"ns":0,"exists":"","*":"Bioethics"},{"ns":0,"exists":"","*":"Clinical Research Associate"},{"ns":0,"exists":"","*":"Clinical research"},{"ns":0,"exists":"","*":"Clinical research ethics"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Common Rule"},{"ns":0,"exists":"","*":"Community advisory board"},{"ns":0,"exists":"","*":"Data monitoring committee"},{"ns":0,"exists":"","*":"Declaration of Helsinki"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"Ethics committee"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"Guidelines for human subject research"},{"ns":0,"exists":"","*":"Human subject research"},{"ns":0,"exists":"","*":"Informed consent"},{"ns":0,"exists":"","*":"Institutional review board"},{"ns":0,"exists":"","*":"Justice (ethics)"},{"ns":0,"exists":"","*":"List of medical ethics cases"},{"ns":0,"exists":"","*":"Medical ethics"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Nuremberg Code"},{"ns":0,"exists":"","*":"Phases of clinical research"},{"ns":0,"exists":"","*":"Privacy for research participants"},{"ns":0,"exists":"","*":"Research ethics"},{"ns":0,"exists":"","*":"Research participant"},{"ns":0,"exists":"","*":"Respect for persons"},{"ns":0,"exists":"","*":"Return of results"},{"ns":0,"exists":"","*":"Right to withdraw"},{"ns":0,"exists":"","*":"Safety monitoring"},{"ns":0,"exists":"","*":"Social research"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":1,"exists":"","*":"Talk:Monitoring in clinical trials"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Merging"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Research participant rights"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Merge"},{"ns":10,"exists":"","*":"Template:Mbox"},{"ns":10,"exists":"","*":"Template:Pagelist"},{"ns":10,"exists":"","*":"Template:DMC"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Merge partner"},{"ns":10,"exists":"","*":"Template:Unreferenced"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Research participant rights"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Pagelist"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Merge-arrows.svg","Question_book-new.svg"],"externallinks":["https://www.nimh.nih.gov/funding/clinical-research/data-and-safety-monitoring-plan-writing-guidance.shtml","http://apps.who.int/medicinedocs/documents/s14084e/s14084e.pdf","https://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-038.html","https://aspe.hhs.gov/report/performance-improvement-2003/center-drug-evaluation-and-research","https://www.fda.gov/downloads/Drugs/Guidances/UCM269919.pdf","https://web.archive.org/web/20090207171103/http://nursing.msu.edu/cracrc.aspx","http://www.ich.org/","http://www.fda.gov/"],"sections":[{"toclevel":1,"level":"2","line":"Aspects of monitoring","number":"1","index":"1","fromtitle":"Monitoring_in_clinical_trials","byteoffset":1326,"anchor":"Aspects_of_monitoring"},{"toclevel":1,"level":"2","line":"Functions of the clinical monitor","number":"2","index":"2","fromtitle":"Monitoring_in_clinical_trials","byteoffset":3181,"anchor":"Functions_of_the_clinical_monitor"},{"toclevel":1,"level":"2","line":"Complexity of monitoring","number":"3","index":"3","fromtitle":"Monitoring_in_clinical_trials","byteoffset":4014,"anchor":"Complexity_of_monitoring"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Monitoring_in_clinical_trials","byteoffset":5268,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Monitoring_in_clinical_trials","byteoffset":5517,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Monitoring_in_clinical_trials","byteoffset":5547,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Monitoring in clinical trials","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q6900510"}]}}